BR112018005305A2 - agente profilático ou terapêutico da queratite fungal - Google Patents
agente profilático ou terapêutico da queratite fungalInfo
- Publication number
- BR112018005305A2 BR112018005305A2 BR112018005305-8A BR112018005305A BR112018005305A2 BR 112018005305 A2 BR112018005305 A2 BR 112018005305A2 BR 112018005305 A BR112018005305 A BR 112018005305A BR 112018005305 A2 BR112018005305 A2 BR 112018005305A2
- Authority
- BR
- Brazil
- Prior art keywords
- mycosis
- cornea
- prevention
- treatment agent
- medical treatment
- Prior art date
Links
- 206010017533 Fungal infection Diseases 0.000 title 1
- 210000004087 cornea Anatomy 0.000 title 1
- 208000024386 fungal infectious disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562220847P | 2015-09-18 | 2015-09-18 | |
| US62/220,847 | 2015-09-18 | ||
| PCT/JP2016/077014 WO2017047597A1 (ja) | 2015-09-18 | 2016-09-13 | 角膜真菌症の予防または治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018005305A2 true BR112018005305A2 (pt) | 2018-10-09 |
Family
ID=58288799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018005305-8A BR112018005305A2 (pt) | 2015-09-18 | 2016-09-13 | agente profilático ou terapêutico da queratite fungal |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10166217B2 (enExample) |
| EP (1) | EP3351244A4 (enExample) |
| JP (1) | JP6639364B2 (enExample) |
| KR (1) | KR20180053340A (enExample) |
| CN (1) | CN108025000A (enExample) |
| BR (1) | BR112018005305A2 (enExample) |
| HK (2) | HK1253545A1 (enExample) |
| MX (1) | MX393608B (enExample) |
| MY (1) | MY183906A (enExample) |
| PH (1) | PH12018500579A1 (enExample) |
| SG (1) | SG11201802091RA (enExample) |
| TW (1) | TWI721015B (enExample) |
| WO (1) | WO2017047597A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112957321B (zh) * | 2021-03-04 | 2022-08-05 | 青岛大学附属医院 | 一种氧化硫酸软骨素改性的那他霉素滴眼液及其制备方法 |
| CN114568490B (zh) * | 2022-04-01 | 2023-12-19 | 眉山职业技术学院(眉山技师学院) | 雷帕霉素在抑制柑橘青霉菌生长中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
| CN101137369A (zh) * | 2005-02-09 | 2008-03-05 | 马库赛特公司 | 用于眼治疗的制剂 |
| US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| ES2507078T3 (es) * | 2007-08-16 | 2014-10-14 | Santen Pharmaceutical Co., Ltd | Formulaciones de rapamicina para tratamiento de la degeneración macular relacionada con la edad |
-
2016
- 2016-09-13 JP JP2016178997A patent/JP6639364B2/ja not_active Expired - Fee Related
- 2016-09-13 TW TW105129822A patent/TWI721015B/zh not_active IP Right Cessation
- 2016-09-13 KR KR1020187010106A patent/KR20180053340A/ko not_active Withdrawn
- 2016-09-13 HK HK18112748.0A patent/HK1253545A1/zh unknown
- 2016-09-13 WO PCT/JP2016/077014 patent/WO2017047597A1/ja not_active Ceased
- 2016-09-13 SG SG11201802091RA patent/SG11201802091RA/en unknown
- 2016-09-13 BR BR112018005305-8A patent/BR112018005305A2/pt not_active Application Discontinuation
- 2016-09-13 HK HK18116109.4A patent/HK1256969A1/en unknown
- 2016-09-13 MX MX2018003381A patent/MX393608B/es unknown
- 2016-09-13 US US15/760,210 patent/US10166217B2/en active Active
- 2016-09-13 CN CN201680054195.5A patent/CN108025000A/zh active Pending
- 2016-09-13 MY MYPI2018000383A patent/MY183906A/en unknown
- 2016-09-13 EP EP16846468.3A patent/EP3351244A4/en not_active Withdrawn
-
2018
- 2018-03-16 PH PH12018500579A patent/PH12018500579A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201802091RA (en) | 2018-04-27 |
| KR20180053340A (ko) | 2018-05-21 |
| MY183906A (en) | 2021-03-17 |
| TWI721015B (zh) | 2021-03-11 |
| WO2017047597A1 (ja) | 2017-03-23 |
| US10166217B2 (en) | 2019-01-01 |
| US20180271841A1 (en) | 2018-09-27 |
| PH12018500579A1 (en) | 2018-09-10 |
| MX393608B (es) | 2025-03-24 |
| JP6639364B2 (ja) | 2020-02-05 |
| EP3351244A4 (en) | 2019-05-01 |
| TW201717943A (zh) | 2017-06-01 |
| CN108025000A (zh) | 2018-05-11 |
| MX2018003381A (es) | 2018-08-15 |
| HK1256969A1 (en) | 2019-10-04 |
| HK1253545A1 (zh) | 2019-06-21 |
| EP3351244A1 (en) | 2018-07-25 |
| JP2017057199A (ja) | 2017-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3601536A4 (en) | TREATMENT PROCESSES | |
| EP3691549C0 (en) | BLOOD OCCLUSION OR RESTRICTION SLEEVE | |
| PT3528717T (pt) | Dispositivos para tratamento de oclusão vascular | |
| EP3335740C0 (en) | Medical hydrogel | |
| DK3347030T3 (da) | Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| PL3936130T3 (pl) | Schemat dawkowania walbenazyny w leczeniu hiperkinetycznych zaburzeń ruchu | |
| DK3474804T3 (da) | Medicinsk forbinding | |
| IL247111A0 (en) | Preventive or therapeutic agent for kidney disease | |
| PL3672954T3 (pl) | Związki, ich sole i ich zastosowanie w leczeniu chorób | |
| IL243485A0 (en) | Methods for treating or preventing ophthalmological conditions | |
| DK3474802T3 (da) | Medicinsk forbinding | |
| HUE055263T2 (hu) | 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére | |
| EP3448263A4 (en) | Electrotherapeutic treatment | |
| IL254142B (en) | Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent | |
| EP3723692A4 (en) | MEDICAL ASSISTANT | |
| PL3600374T3 (pl) | Leczenie zakażenia układu oddechowego | |
| EP3424557A4 (en) | INTRAKARDIAL DEFIBRILLATION CATHETER | |
| IL269083A (en) | Methods for preventing and treating heart disease | |
| EP3710095C0 (en) | FRICTIONLESS CATHETER | |
| HUE060517T2 (hu) | Immunhiányos betegség kezelésére szolgáló eljárások | |
| IL253854B (en) | Mebendazole polymorph for treatment and prevention of tumors | |
| EP3597225A4 (en) | TREATMENT PROCESS | |
| EP3398537A4 (en) | CAP FOR LEFT HEART OF EAR | |
| DK3474803T3 (da) | Medicinsk forbinding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |